Novo Nordisk confirms start of phase I robotic pill trial

In its Q1 report, the pharmaceutical company revealed that the phase I trial of its SOMA capsule has begun.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
by christopher due karlsson, translated by catherine brett

Novo Nordisk has confirmed that it has started a phase I trial of its SOMA robotic pill, currently known as DV3395.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading